View All Key Stats
INCY Key Stats
| Income Statement | |
| Revenue (TTM) | 1.536B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.57 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -313.14M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 94.97% |
| Profit Margin (Quarterly) | -33.69% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 13.26B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 8.397 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 8.132 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | -114.52M |
| Return on Equity (TTM) | Upgrade |
View All INCY News
INCY News
-
WireHeadlineTime (ET)
-
Business Wire04/26 08:00
-
Business Wire04/25 17:38
-
Yahoo04/25 10:33
-
Yahoo04/25 08:30
-
MT Newswires04/24 16:20
-
MT Newswires04/24 15:50
-
MT Newswires04/24 13:22
-
Yahoo04/24 11:59
-
MT Newswires04/24 11:55
-
MT Newswires04/24 11:49
View All Events
INCY Events
| Date | Type | Description |
|---|---|---|
| 08/01/2018 | Misc | Incyte Corp Second Quarter Earnings Conference Call in 2018 |
| 08/01/2018 | Earnings | Incyte Corp Second Quarter Earnings Results in 2018 |
| 05/01/2018 08:00 EDT | Misc | Incyte Corp First Quarter Earnings Conference Call in 2018 |
| 05/01/2018 | Earnings | Incyte Corp First Quarter Earnings Results in 2018 |
| 02/15/2018 10:00 EST | Misc | Incyte Corp Fourth Quarter Earnings Conference Call in 2017 |
| 02/15/2018 | Earnings | Incyte Corp Fourth Quarter Earnings Results in 2017 |
| 02/15/2018 | Misc | Incyte Corp Annual Report in 2017 |
| 10/31/2017 10:00 EDT | Misc | Incyte Corp Third Quarter Earnings Conference Call in 2017 |
| 10/31/2017 | Earnings | Incyte Corp Third Quarter Earnings in 2017 Release |
| 09/09/2017 11:00 EDT | Misc | Incyte ESMO 2017 Conference Call |
INCY Fundamentals
Income Statement View Statement
INCY Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
INCY One Page Reports
- One Page Report Download
INCY Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 62.61 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.incyte.com
- Investor Relations URL: http://www.incyte.com/ir/investor-overview.aspx
- HQ State/Province: Delaware
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Large Cap/Growth
- Next Earnings Release: May. 01, 2018
- Last Earnings Release: Feb. 15, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Incyte Corp is a biopharmaceutical company. It discovers, develops and commercializes proprietary therapeutics. Its product JAKAFI, a JAK1 and JAK2 inhibitor is used for treatment of patients with intermediate or high risk myelofibrosis.
INCY Excel Add-In Codes
- Name: =YCI("INCY","name")
- Description: =YCI("INCY","description")
- Sector: =YCI("INCY","sector")
- Industry: =YCI("INCY","industry")
- Est. Current Fiscal Year End: =YCI("INCY","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other INCY Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- INCY Tweets Stocktwits
Advertisement
